or Try an Advanced Search...

    ETF Components for BIS - ProShares UltraShort Nasdaq Biotechnology


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    AMGN B -0.65 8.14
    GILD F 1.27 7.41
    VRTX B 0.72 7.21
    BIIB D -2.24 6.12
    ILMN F -0.48 5.67
    REGN C -1.05 4.13
    INCY D -0.33 2.09
    BMRN F -4.27 1.91
    ALNY D 2.59 1.60
    VTRS D -0.45 1.35
    SNY C -0.39 1.29
    NBIX B -0.06 1.16
    SRPT C 0.18 1.15
    NVCR C 5.32 1.10
    JAZZ F 0.68 1.03
    TECH C -0.79 1.02
    IONS F -4.06 1.02
    GH C 1.90 0.96
    AMRN D -2.51 0.85
    MRNA C 2.80 0.83
    BGNE D 3.73 0.83
    ACAD F -1.79 0.81
    ASND D -1.00 0.77
    EXEL F 0.52 0.73
    ARWR F -0.16 0.65
    BLUE F -1.87 0.65
    BBIO C 3.57 0.51
    ALLK D 22.36 0.49
    UTHR B -0.17 0.49
    NKTR C -1.64 0.48
    SAGE F 2.56 0.48
    BPMC C -0.14 0.48
    FGEN F 4.20 0.47
    DCPH A 0.00 0.43
    AGIO B -0.51 0.43
    CRSP F -2.26 0.42
    RARE D 3.62 0.42
    ADPT D -4.62 0.42
    MEDP D -3.10 0.40
    PTCT C 1.10 0.40
    ARGX F -0.10 0.40
    AXSM C 1.87 0.38
    ALLO F 1.01 0.37
    GRFS D -0.26 0.36
    IOVA D -2.34 0.36
    ALKS F 1.33 0.36
    KOD F 0.00 0.35
    HALO B -0.94 0.35
    QURE F 0.20 0.35
    FOLD F -1.66 0.32
    APLS F 0.19 0.31
    XNCR C 5.50 0.26
    MYGN C -0.20 0.26
    DNLI C -2.97 0.26
    ZLAB D -4.41 0.24
    IRWD F 1.22 0.24
    ARVN D -0.68 0.24
    INSM F 0.68 0.23
    FATE D -2.36 0.23
    PCRX C 4.75 0.22
    GLPG F 1.62 0.22
    ITCI D -0.46 0.21
    RGNX F -1.36 0.21
    ESPR D 12.61 0.19
    EDIT F -1.83 0.19
    LGND C -0.87 0.19
    INVA C 0.88 0.18
    VCYT D -0.64 0.18
    ALEC F -2.83 0.18
    TBPH C -2.54 0.17
    YMAB F -2.71 0.16
    CHRS F -0.46 0.16
    HCM B -2.74 0.15
    NGM D 0.00 0.15
    SUPN D 1.46 0.15

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Development Biology Pain S&P 500 Immune System Immunology Infectious Diseases Disease Genetics Inflammation Monoclonal Antibodies Nasdaq 100 Organ Systems Cholesterol Diabetes
    Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies

    Recent News for ProShares UltraShort Nasdaq Biotechnology & its Holdings

    Date Stock Title
    May 16 TECH Reddit Stock Pops On Partnership With OpenAI: The Details
    May 16 TECH DXC Technology Stock Drops On Q4 Results, FY25 Outlook: Here's Why
    May 16 MRNA Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
    May 16 MRNA Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
    May 16 SNY Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
    May 16 HALO Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock
    May 16 IOVA 4 Small-Cap Value Stocks That Could Go Parabolic
    May 16 BLUE Is Bluebird Bio Stock a Buy?
    May 16 SNY If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now
    May 16 TECH Netflix's NFL Games Through 2026 Set To Drive Explosive Subscriber, Ad Revenue Growth, Says Analyst
    May 16 IONS Biogen and Ionis drop ALS candidate after trial setback
    May 16 BIIB Biogen and Ionis drop ALS candidate after trial setback
    May 16 TECH Microsoft's Massive €4 Billion Investment In French Tech And A Stunning 9% Stock Recovery Could Propel Their Shares Towards $500
    May 16 FATE Alibaba To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Thursday
    May 16 GH Guardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease Week
    May 16 IONS REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
    May 16 BIIB REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
    May 16 BIIB Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
    May 16 IONS Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
    May 16 BIIB Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
    The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. It is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Leveraged ETF Ultra ETF Inverse ETF Bear Market ETF Industry Classification Nasdaq Biotechnology Index Nasdaq Biotech Nasdaq Biotechnology Total Return Index
    Back to the Main BIS Page...